ARTiBIOME: Observational Study on the Effect of HIV and ART on Gut Microbiome

CompletedOBSERVATIONAL

Enrollment

120

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

December 1, 2022

Study Completion Date

March 1, 2023

Conditions

HIV Infections

Interventions

DRUG

Integrase strand transfer inhibitors

Integrase strand transfer inhibitors as post-exposure prophylaxis or as antiretroviral treatment

Trial Locations (1)

Hospital Ramón y Cajal and Hospital Clínico San Carlos, Madrid

All Listed Sponsors

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

OTHER

NCT04460924 - ARTiBIOME: Observational Study on the Effect of HIV and ART on Gut Microbiome | Biotech Hunter | Biotech Hunter